TY  - GEN
AU  - Kim,Su-Hyun
AU  - Kim,Ho Jin
TI  - Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy
SN  - 2168-6157
PY  - 2018///1030
KW  - Humans
KW  - Immunologic Factors
KW  - Neuromyelitis Optica
KW  - Rituximab
N1  - Publication Type: Journal Article; Comment
UR  - https://doi.org/10.1001/jamaneurol.2016.5933
ER  -